RAINBOW2025-01-012025-03-31RAINBOW2025-03-31RAINBOW2024-03-31RAINBOW2024-04-012025-03-31RAINBOW2025-01-012025-03-31in-capmkt:OtherExpenses1MemberRAINBOW2025-01-012025-03-31in-capmkt:OtherExpenses2MemberRAINBOW2025-01-012025-03-31in-capmkt:OtherExpenses3MemberRAINBOW2025-01-012025-03-31in-capmkt:OtherExpenses4MemberRAINBOW2025-01-012025-03-31in-capmkt:OtherExpenses5MemberRAINBOW2025-01-012025-03-31in-capmkt:OtherExpenses6MemberRAINBOW2025-01-012025-03-31in-capmkt:OtherExpenses7MemberRAINBOW2025-01-012025-03-31in-capmkt:OtherExpenses8MemberRAINBOW2025-01-012025-03-31in-capmkt:OtherExpenses9MemberRAINBOW2025-01-012025-03-31in-capmkt:OtherExpenses10MemberRAINBOW2024-04-012025-03-31in-capmkt:OtherExpenses1MemberRAINBOW2024-04-012025-03-31in-capmkt:OtherExpenses2MemberRAINBOW2024-04-012025-03-31in-capmkt:OtherExpenses3MemberRAINBOW2024-04-012025-03-31in-capmkt:OtherExpenses4MemberRAINBOW2024-04-012025-03-31in-capmkt:OtherExpenses5MemberRAINBOW2024-04-012025-03-31in-capmkt:OtherExpenses6MemberRAINBOW2024-04-012025-03-31in-capmkt:OtherExpenses7MemberRAINBOW2024-04-012025-03-31in-capmkt:OtherExpenses8MemberRAINBOW2024-04-012025-03-31in-capmkt:OtherExpenses9MemberRAINBOW2024-04-012025-03-31in-capmkt:OtherExpenses10MemberRAINBOW2025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1RAINBOW2024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1RAINBOW2025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares543524RAINBOWNOTLISTEDINE961O01016Rainbow Childrens Medicare LimitedMain BoardEquity2024-04-012025-03-312025-05-242025-05-17INRMillionsQuarterlyFourth quarterSingle segmentThe business of running multi specialty pediatric and obstetrics and gynecology hospital.2025-05-2415:00:002025-05-2418:00:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated370107000014527000038463400004704100000054316000018121000034163000015402400003076650000769690000076969000019781000063500002041600000565530000000056553000030050000595580000563350000218000059319000023900001015520000105.555.55005.555.55Notes <BR> <BR> 1. The above statement of audited consolidated financial results of Rainbow Childrens Medicare Limited the Company and its subsidiaries the Company and its subsidiaries together referred to as the Group which have been prepared in accordance with Indian Accounting Standards Ind AS prescribed under section 133 of Companies Act 2013 the Act read with relevant rules issued thereunder other accounting principles generally accepted in India and guidelines issued by the Securities and Exchange Board of India SEBI were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their respective meetings held on 24 May 2025. The statutory auditors have expressed an unmodified audit opinion on these results. <BR> <BR> 2. The consolidated figures for the fourth quarter ended 31 March 2025 are the balancing figures between published audited figures in respect of the full previous financial year and the published unaudited year to date figures up to the third quarter of the relevant financial year. Also the figures up to the end of third quarter were only reviewed and not subjected to audit. <BR> <BR> 3. The Board of Directors of the Company on 24 May 2025 recommended dividend for the financial year 2024 25 Rs.3 per Equity Share of Rs.10 each aggregating to Rs. 304.66 million. The payment is subject to approval of the shareholders at the ensuing Annual General Meeting of the Company. <BR> <BR> 4. Refer Results Pdf. <BR> <BR> 5. Pursuant to the resolutions passed by the Board of Directors on 09 February 2025 and by the Shareholders on 02 April 2025 the Company approved The Rainbow Childrens Medicare Limited Employee Stock Option Scheme 2025 ESOP 2025 in compliance with the SEBI Share Based Employee Benefits and Sweat Equity Regulations 2021 SEBI SBEB SE Regulations. The ESOP 2025 scheme is for issue of employee stock options to eligible employees which may result in an issuance of a maximum number of 1015000 Equity Shares. Upon exercise and payment of the exercise price an option holder will be entitled to be allotted one Equity Share per employee stock option. The exercise price per option shall be determined by the Nomination and Remuneration Committee subject to a maximum discount of up to 20% from the market price of shares as on the date of grant. <BR> <BR> 6.The Group is principally engaged in a single business segment viz. rendering medical and healthcare services. Further the business operation of the group are concentrated in India and hence the group is considered to operate only in one geographical segment. <BR> 7.The consolidated financial results for the quarter and year ended 31 March 2025 are available on the BSE Limited website URL www.bseindia.com the National Stock Exchange of India Limited website URL www.nseindia.com and on the Companys website URL www.rainbowhospitals.in. <BR> 8.The audited consolidated financial results include the financial results of Rainbow Childrens Medicare Limited and the financial results of its subsidiaries Rainbow C R O Private Limited Rainbow Fertility Private Limited Rainbow Women Childrens Hospital Private Limited Rainbow Speciality Hospitals Private Limited Rosewalk Healthcare Private Limited Rainbow Childrens Hospital Private Limited and its other consolidating entity Rainbow Childrens Hospital Foundation. <BR> 2024-04-012025-03-31AuditedConsolidated151586600005100800001566874000019492000000020636700007245500001384400000624691000012368730000330001000003300010000892930000-351900008577400000244227000000002442270000-610000244166000024342400008030000243341000082500001015520000101366641000023.9723.840023.9723.84Professional Fees to Doctors944610000Canteen expenses58670000Contract wages109500000Housekeeping expenses20480000Power and fuel61580000Lab and investigations39840000Repairs and maintenance84650000Rates and taxes44540000Business promotion and advertisement53670000Other Expenses122700000Professional Fees to Doctors3690210000Canteen expenses271050000Contract wages400660000Housekeeping expenses82270000Power and fuel277210000Lab and investigations171990000Repairs and maintenance327680000Rates and taxes168390000Business promotion and advertisement309440000Other Expenses54801000013878150000277660000001032800006930000003000002977200003197400006174900002958900002662500001544565000027569000057072800007730100002025500002000003000000010547000007767740000103680000177100000832421000000237698600001015520000136664100001468193000068170000147501000000000741679000074167900009725000000075140400000102020000807660000909680000397090000130677000013199000066960000001505720000901976000023769860000724550000-35910000-776300000-10642000000009546000000013844000000563800000-1858000001400000144290000-12710000-2810200000-7853000006660000015125000004812510000000855930000039565800000000000080000014567000000000000000000000002219000000-1443980000-2677980000005000000000000873100000304640000000-11772400001013600000101360000101190000202550000Re-measurement (loss)/gain on defined benefit obligation4009000040090000Re-measurement (loss)/gain on defined benefit obligation-980000-98000010040000-3700000030050000-610000AuditedtrueS.R. BATLIBOI & ASSOCIATES LLPtrue2027-07-31